0001438533-26-000063 Sample Contracts

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. EXCLUSIVE LICENSE AND...
Exclusive License and Collaboration Agreement • August 4th, 2026 • Travere Therapeutics, Inc. • Pharmaceutical preparations • New York

This Exclusive License and Collaboration Agreement (the “Agreement”) is entered into as of June 1, 2026 (the “Execution Date”), by and between Everest Medicines (Singapore) Pte. Ltd., a private company organized and existing under the laws of Singapore, having a registered office at 36 Robinson Road, #20-01 City House, Singapore 068877 (“Everest”), and Travere Therapeutics, Inc., a Delaware corporation, having a place of business at 3611 Valley Centre Drive, Suite 300, San Diego, California 92130, USA (“Licensee”) and, solely for the purpose of Section 16.15 (Parent Guarantee), Everest Medicines Limited, a Cayman Islands company with limited liability having an address at PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands (“Parent”).